The Risk of Multiple Sclerosis Relapse After Vaccination: Can a Population-Based Study of Mass Vaccination End the Longstanding Debate?

Abboud, Hesham; Farez, Mauricio Franco

dc.contributor.author	Abboud, Hesham
dc.contributor.author	Farez, Mauricio Franco
dc.date.accessioned	2024-10-21T13:17:51Z
dc.date.available	2024-10-21T13:17:51Z
dc.date.issued	2024-08-10
dc.identifier.citation	Abboud H, Farez MF. The Risk of Multiple Sclerosis Relapse After Vaccination: Can a Population-Based Study of Mass Vaccination End the Longstanding Debate? Neurology. 2024 Sep 10;103(5):e209761. doi: 10.1212/WNL.0000000000209761. Epub 2024 Aug 14.	es_ES
dc.identifier.uri	https://doi.org/10.1212/wnl.0000000000209761
dc.identifier.uri	https://repositorio.fleni.org.ar/xmlui/handle/123456789/1217
dc.language.iso	eng	es_ES
dc.publisher	Lippincott Williams & Wilkins	es_ES
dc.subject	Multiple Sclerosis	es_ES
dc.subject	Esclerosis Múltiple	es_ES
dc.subject	Vaccination	es_ES
dc.subject	Vacunación	es_ES
dc.title	The Risk of Multiple Sclerosis Relapse After Vaccination: Can a Population-Based Study of Mass Vaccination End the Longstanding Debate?	es_ES
dc.type	info:eu-repo/semantics/article	es_ES
dc.description.fil	Fil: Abboud, Hesham. Fleni. Centro para la Investigación de Enfermedades Neuroinmunológicas; Argentina.
dc.description.fil	Fil: Farez, Mauricio Franco. Fleni. Centro para la Investigación de Enfermedades Neuroinmunológicas; Argentina.
dc.relation.ispartofVOLUME	103
dc.relation.ispartofNUMBER	5
dc.relation.ispartofPAGINATION	e209761
dc.relation.ispartofCOUNTRY	Estados Unidos
dc.relation.ispartofCITY	Hagerstown
dc.relation.ispartofTITLE	Neurology
dc.relation.ispartofISSN	1526-632X
dc.type.snrd	info:ar-repo/semantics/artículo	es_ES